chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No adverse effects were reported; The nurse reported a 48 year old male patient was administered his first dose of GARDASIL 9.; This spontaneous report has been received from a nurse regarding to a 48-year-old male patient. The patient's concurrent conditions, medical history, concomitant medications, drug allergies or reactions were not provided.   On 06-JUN-2019, the patient was vaccinated with the first dose hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, route of administration and anatomical location of vaccine were not provided) lot # R027577, because he was at a high risk of contracting and sexual transmitted disease (STD). No adverse effects were reported.
Given DTP on 5FEB92 w/in 24 hrs had focal sz, (inc temp/at same time) which generalized & lasted 45 minutes; Ct Scan nl; EEG nl x/for slowing; LP-nl; felt sz due to DTP & set off underlying sz disorder;
Information has been received from a doctor of pharmacy concerning a 5 year old male pt who in December of 1997 was vaccinated with MMR and Varicella vaccines. In January of 1998, the pt was dx with CNS complications including ataxia, myoclonus, opsoclonus.
Syncopy, persistent fever (101 deg), dizziness, vertigo, sleeplessness, high blood pressure, rapid pulse
This case was reported by a healthcare professional to a sales representative and described the occurrence of the redness and swelling at the injection site in a 4-year-old subject (unknown gender) who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix, GlaxoSmithKline). On an unspecified date in either March 2006 or April 2006, the subject received the 5th dose of Infanrix in an unspecified thigh (lotAC14B018AA). On the same day, the patient received injections of poliomyelitis virus vaccine (IPOL, Aventis Pasteur) and measles mumps and rubella virus vaccine (M-M-R II, Merck). the injection sites for IPOL and MMR II were not provided. At an unspecified time after vaccination with Infanrix, on an unspecified date on or before 11 April 2006, the subject experienced redness and swelling at the injection site of Infanrix. The outcome of the events was not reported. The nurse considered the events to probably be related to vaccination with Infanrix.
Pain and throbbing in arm where I received the shot, especially the following morning.  It?s been recurring pain especially when I move my arm in certain ways. No health insurance at the moment, haven?t seen a physician about this or received an MRI.  The more concerning though is recurring vertigo I?ve been experiencing. I have never had it before, but a few days after I?m receiving the dose my eyes started shaking involuntarily and I had difficulty keeping my balance.  It went away after a bit, but has happened a number of times over the last two weeks.  I?m obviously hoping it just goes away.
Patient said the rash didn't start right away, maybe a week later. A few pustules broke out in the beginning and advanced to several more down her left arm. They had pus, swelled, and bled. She said they were itchy and warm. OTC Benadryl cream did not help, so she saw Dr today (10-24-18). He prescribed Prednisone 20mg (1 bid for 5 days, then 1 tablet daily for 5 days) and Minocycline 100mg 1 capsule daily for 10 days.
I cannot be entirely sure if this is due to the vaccine. However, I have never had this symptom before.  And it occurred within the 24 hrs post vaccine and continues to persist. I felt feverish and had myagia for a day which settled with Ibuprofen. However I  also developed right middle metatarsal inflammation and joint swelling with pain which is ongoing.   thought it will settle down., but still persisting  for 6 days currently.
7/18/2021 Patent presemted to ED with a chief complaint of chest pain for the last 3 days associated with shortness of breath. Refers has been using ibuprofen achieving minimal relief. Received COVID 19 vaccinate in April (Johnson & Johnson). Upon initial evaluation on ED VS: stable. Laboratories revealed elevated creatinine and COVID 19 TEST Positive. EKG: Sinus rhythm, T wave abnormalities. A chest x ray: IMPRESSION:  Left lower lung airspace disease. CT angio showed Acute pulmonary embolism, left lower lobe, nonocclusive. COVID-19 infection considered asymptomatic and no treatment required for this. Discharged home on 7/19/21.
This spontaneous report as received from a medical assistant refers to unspecified patients of unknown age and gender. No concurrent conditions, medical history or concomitant medications were reported. On an unknown date, the unspecified patients were vaccinated with (Oka-Merck) PROQUAD lot # K011314, expiration date 14-FEB-2016 and lot # L006390, expiration date 25-AUG-2016 (total of 9 doses, number of each lot administered were not specified) (dose, strength, route of administration were not reported). It was reported that suspect vaccine had been improperly stored. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
patient came back 4 days later stating that her lower part of her bicep was red and hurting. Stated she felt feverish every day but not currently.
Patient received a Pneumovax yesterday in the left deltoid, has redness and swelling in this area one day later.  No fever or chills.  No difficulties with breathing.  Patient believes that he received a Pneumovax several years ago, but does not know for sure. Treated with diphenhydramine, naproxen, and cephalexin. Symptoms resolved.
made my arm sore; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 31-JUL-2022 Reporter's Comments: This case was received from consumer via interactive digital media. The patient received second shot and made his/her arm sore for a few days. The follow-up could not be possible as no contact details were available.
rash on left arm; injection site itching; pain at injection site; A spontaneous report was received from a consumer who was also a 49-years-old patient who received Moderna's COVID-19 vaccine and experienced pain at injection site, rash on left arm above injection and itching.  Patient's medical history was not provided, and concomitant medicines taken by the patient, is given  On 29 Jan 2021, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 04 feb 2021, the patient experienced pain at injection site, rash on left arm above injection and itching. Treatment included cortisone for 2-days  Caller received his first vaccine 29JAN2021 and experienced adverse events. Symptoms included pain at injection site, rash on left arm above injection and itching. Applied cortisone 2-days  Action taken with mRNA-1273 was not reported. The outcome of the events, pain at injection site, rash on left arm above injection and itching, was considered recovered/resolved
Pharmacy intern gave a flu shot to the patient. 10 minutes later the patient had fallen to the ground. Patient lied on the ground for about 5 minutes and then got up. Patient states they are feeling fine. Paramedics came for assistance.
Information has been received from a Health care Professional concerning a 26 year old female police officer with muscle sensitivity who on 02-NOV-2006 was vaccinated in left deltoid with a 2nd dose of HPV, lot # 653736/0868F. On 23-NOV-2006 the patient was sore at muscle site on an off for 3 days, and she still noticed sensitivity three weeks post injection. No medical attention was sought. The patient reported as recovered. No further information is available. Follow-up received 04/03/2009. On her visit on 16-JAN-2007 the patient reported the event. The patient reported as recovered. No further information is expected.
pt noticed tenderness & redness @ inj site;redness extended down back of lt arm approx 4-5inches from inj site;in addition to redness down arm, area was hot to touch;
Vaccine was administered 12 hours after manufacturer expiration date. The patient did not report any unusual side effects
Patient's husband described: within 2 hrs developed itching, burning of skin at site of vaccine. Continued with redness, burning for 5 days. Symptoms have resolved
No adverse event; Moderna bivalent should have discarded the vial  on 13-Jun-2023, but the dose was administered on 14-Jun-2023; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna bivalent should have discarded the vial  on 13-Jun-2023, but the dose was administered on 14-Jun-2023) and NO ADVERSE EVENT (No adverse event) in a 71-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch nos. 065H22A and AS7165B) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (lot-EN9581) on 15-Feb-2021, PFIZER BIONTECH COVID-19 VACCINE (lot-EN6204) on 08-Mar-2021 and PFIZER BIONTECH COVID-19 VACCINE (lot-FF2588) on 25-Sep-2021. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.   On 30-Sep-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 14-Jun-2023, received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to .5 milliliter. On 14-Jun-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna bivalent should have discarded the vial  on 13-Jun-2023, but the dose was administered on 14-Jun-2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna bivalent should have discarded the vial  on 13-Jun-2023, but the dose was administered on 14-Jun-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna bivalent should have discarded the vial  on 13-Jun-2023, but the dose was administered on 14-Jun-2023).    No concomitant medication was reported. It was reported that It was a brand new vial that was pulled from the freezer.  The new vials in the freezer don't have expiration dates and there was no way to know that it was expired. Th vial size was 2.5 mL and was stored in the refrigerator on 12-Jun-2023. The vial did not undergo any temperature excursions.  No treatment medication was reported.
doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   On 04-Nov-2021, the vial was placed in the refrigerator. The vial did not had any temperature excursion and the patient had no adverse event.  No concomitant medications were reported.  No treatment information was reported.
patient has developed blood clot after getting the J&J shot on 4/6/2021. The patient has had a sore arm since the day he got his vaccine. According to his wife, he started to feel weak on Sunday 5/30/2021. She said his hands were cold that day too, then by Tuesday his fingers turned white, this is when she took him to the hospital and found out about the blood clot. His wife also mentioned that after examination, they found out that he has an extra rib that was pressing on the brachial artery and that might have caused the blood clot. It doesn't seem to be sure that the blood clot was caused by the covid vaccine or not
The PREVNAR injection site is two inches from the flu injection site. The PREVNAR site is hot, raised, red, itchy, and tender/sore/swollen.
Hospitalization for COVID symptoms on dates 5/16/2022- 5/29/2022.  Treated with Duoneb inhaler, vitamin C 1000mg daily, vitamin D3 25mcg daily, dexamethasone 6mg IV daily, zinc sulfate 50mg daily, Spiriva inhaler daily, and Remdesivir daily.
cellulitis- redness , warmth,inflamation, and axillary lymph tenderness
the arm felt like someone took a hammer to it for about 3 to 5 days; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via social media on 30-Nov-2020.  This case involves a patient of unknown demographics who felt like someone took a hammer to the arm for about 3 to 5 days (pain in extremity), after receiving INFLUENZA VACCINE.  The patient's medical history, past medical treatments, past vaccinations, family history and concomitant medications were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiration date not reported) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient felt like someone took a hammer to the arm for about 3 to 5 days (pain in extremity), (non-serious event) (unknown latency) following the administration of INFLUENZA VACCINE.  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information available on the batch number for this case.
Shortness of breath & dizziness/vertigo. Onset: 05/09/2021 7:00 AM. Still ongoing as of 05/11/2021 12:30 PM.
Employee reported they experienced uveitis (reportedly diagnosed at visit with "eye doctor") with an onset of about two weeks from getting the first dose of the Pfizer SARS-CoV-2 vaccine.
A week after receiving my first injection I started to notice a tender and itchy raised rash on my back (left side). I saw the dermatologist who diagnosed me with shingles and placed me on a course of Valtrex.
Pt given Tdap vaccine instead of Td, when the patient was 65 years of age.  There were no adverse events.
Patient noted that upon wake up next mornging she experience shoulder pain and was unable to move her arm.
Patient described a red and swollen area around the injection site roughly 4x6 inches. The affected area is also warm to the touch.
Pt C/O feeling nauseated, lightheaded after vaccines and later day pain his (R) arm. Felt numb all day. Subsided on its own. Spoke to pt's mother no further problems the following day.
17 year old got the vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old got the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old got the vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old got the vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Information has been received from a consumer, concerning her daughter who on an unspecified date was vaccinated with a dose of ATTENUVAX. Subsequently, after the patient received the vaccination she experienced a fever and developed an injection site rash. Follow up information received from the consumer indicated that her daughter also experienced flushing in her face. At the time of the report, the outcome was not reported. Follow up information has been received from the consumer concerning her daughter. The patient's mother reported that her daughter developed purpura after she received a dose of ATTENUVAX (lot # 659617/0448X). At the time of the report, the patient's status was unknown. Follow up information has been received from the consumer who reported that the patient had fever 105 degrees F (11-14 days into the vaccine), rash described as some red blotchy, and purple, small spots on facial area, temple area and blotchy face. Then this subsided with in the next two weeks. Then a fever and rash occurred about 4 days later. Additional information has been requested.
This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felling bad), BONE PAIN (has achy bones), INFLUENZA LIKE ILLNESS (basically they feel like they have the flu), HEADACHE (headaches) and LYMPHADENOPATHY (swollen glands) in a 77-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Nov-2021, the patient experienced FEELING ABNORMAL (felling bad). On an unknown date, the patient experienced BONE PAIN (has achy bones), INFLUENZA LIKE ILLNESS (basically they feel like they have the flu), HEADACHE (headaches) and LYMPHADENOPATHY (swollen glands). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (felling bad), BONE PAIN (has achy bones), INFLUENZA LIKE ILLNESS (basically they feel like they have the flu), HEADACHE (headaches) and LYMPHADENOPATHY (swollen glands) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2021, Body temperature: 100.6 (High) a temperature 100.6,°F.         No concomitant medication were reported.
When VAR entered into Alert, second dose indicated 'series not valid'. Client received 2nd dose 22 days after her 1st dose of Moderna.  Followed up with client to notify her of this and what her Alert record indicates, and encouraged her to let her provider know.
Strong headache starting around 6pm (approximately 3 hours after shot); Sore arm around injection site starting about an hour after shot; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 13-year-old, non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the right arm on 13May2021 at 15:00 (at the age of 13-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was reported as none. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medication within two weeks of the COVID-19 vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 13May2021 at 16:00, the patient experienced sore arm around injection site which started about an hour after the shot which continued through the next day. On 13May2021 around 18:00, the patient experienced a strong headache (approximately 3 hours after shot). On 13May2021, in the evening of the vaccination day and the day after the shot, the patient experienced fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of events sore arm around injection site and fatigue. Therapeutic measures were taken as a result of the event strong headache which included treatment with over the counter (OTC) TYLENOL and headache went away in a few hours. The clinical outcome of events sore arm around injection site, strong headache and fatigue was resolved on an unknown date in May2021.  No follow-up attempts are needed. No further information is expected.
Mom phoned to clinic this am (4/14/08) stating over the weekend, patient was running temperature of 101-102.5.  Sunday patient broke out with rash on face.  Rash has now spread to chest, abdomen, and hands.  As of this morning (4/14/08) patient is afebrile.  Mom states patient is in good spirits.  Chicken pox protocol started.
Stabbing chest pains 12 hours after the shot that lasted for around another 24 hours. The chest pains came along with more normal symptoms such as chills, body aches, and a fever. While the side effects and shooting stabbing pains went away, I still feel strained chest pains from time to time.
Low grade fever of 101.4, achy muscles, tiredness, and cannot lift left arm above my head without feeling extreme pain.
Per pt's mother: approx. 20 mins after vaccine administration, pt complained of feeling warm and itchy, and had rash on back and armpits, gave Benadryl, oatmeal bath, hydrocortisone topically, next a.m. rash was head-to-toe "including scalp and private area," took to ER, prescribed prednisone and Atarax.
10 days after the vaccination, my vaccinated arm suddenly had a red swollen area probably 3"x3" and it was warm, sore and itched.  I went to the doctor and it was determined that I had cellulitis and was given an antibiotic.  It was a five day dose and it cleared it up.
lymph nodes in left underarm quite tender and painful - this is the most disturbing and uncomfortable side effect bad taste in mouth (like I've smoked a cigar), no amount of tooth brushing will eliminate it slight headache